特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
939176

感染予防・管理:世界市場の展望(2018-2027年)

Infection Prevention & Control - Global Market Outlook (2018-2027)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 140 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.89円
感染予防・管理:世界市場の展望(2018-2027年)
出版日: 2020年05月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 140 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染予防・管理の市場は予測期間中5.4%のCAGRで推移し、2018年の1395億9000万米ドルから、2027年には2240億8000万米ドルの規模に成長すると予測されています。自社・院内・委託による滅菌対策の導入拡大、院内感染(HAIS)の増加、手術件数の増加、政府によるイニシアチブの拡大、高齢者人口の急増などの要因が同市場の成長を推進しています。しかし一方で、医療者のワクチン接種率の低さが市場のさらなる成長の障壁となる可能性があります。

当レポートでは、世界の感染予防・管理の市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、薬剤区分・感染症区分・エンドユーザー・地域/主要国など各種区分別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向の分析

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • エンドユーザー分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の感染予防・管理市場:抗菌薬別

  • イントロダクション
  • 抗真菌薬
  • ワクチン
  • 抗菌薬
  • 抗ウイルス薬

第6章 世界の感染予防・管理市場:感染区分別

  • イントロダクション
  • ヘルスケア関連
    • コミュニティ感染
    • 院内感染
  • 微生物感染
    • 真菌感染症
    • ウイルス感染
    • クロストリジウムディフィシル感染症
    • エクセロヒルム
    • 細菌感染症

第7章 世界の感染予防・管理市場:製品・サービス機器別

  • イントロダクション
  • 感染予防用品
    • 消毒剤
    • オートクレーブ
    • 個人用保護具
    • 安全性強化型医療機器
    • 滅菌用品
    • 医療廃棄物処理用品
  • 感染防止装置
    • 滅菌装置
    • 洗浄/消毒装置
    • 内視鏡リプロセッサー
    • その他

第8章 世界の感染予防・管理市場:エンドユーザー別

  • イントロダクション
  • 薬剤
    • 個人・患者
    • 介護・シニアケアセンター
  • 機器
    • 医療ラボ
    • 製造ユニット
    • 病院・クリニック
    • ライフサイエンス産業

第9章 世界の感染予防・管理市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第10章 主な展開

  • 契約・提携・協力・JV
  • M&A
  • 新製品の発売
  • 拡張
  • その他の主要戦略

第11章 企業プロファイル

  • Danaher Corporation
  • Johnson & Johnson
  • Becton, Dickinson, and Company
  • 3M Company
  • Baxter International
  • Ansell Limited
  • Belimed AG
  • Aquionics
  • Bemis Company Incorporated
  • Abbott
  • Braun (B.) Melsungen AG
  • Cantel Medical Corporation
  • Cardinal Health Incorporated
  • Covidien
  • Henkel
  • Simens
  • Getinge Group
  • Hollister
  • Medtronics
  • CCP Industries
図表

List of Tables

  • Table 1 Global Infection Prevention & Control Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Infection Prevention & Control Market Outlook, By Antimicrobial Drugs (2017-2027) ($MN)
  • Table 3 Global Infection Prevention & Control Market Outlook, By Anti-Fungal Drugs (2017-2027) ($MN)
  • Table 4 Global Infection Prevention & Control Market Outlook, By Vaccines (2017-2027) ($MN)
  • Table 5 Global Infection Prevention & Control Market Outlook, By Anti-Bacterial Drugs (2017-2027) ($MN)
  • Table 6 Global Infection Prevention & Control Market Outlook, By Anti-Viral Drugs (2017-2027) ($MN)
  • Table 7 Global Infection Prevention & Control Market Outlook, By Infection Type (2017-2027) ($MN)
  • Table 8 Global Infection Prevention & Control Market Outlook, By Healthcare Associated Infections (2017-2027) ($MN)
  • Table 9 Global Infection Prevention & Control Market Outlook, By Community Acquired Infection (2017-2027) ($MN)
  • Table 10 Global Infection Prevention & Control Market Outlook, By Hospital Acquired Infection (2017-2027) ($MN)
  • Table 11 Global Infection Prevention & Control Market Outlook, By Microbial infections (2017-2027) ($MN)
  • Table 12 Global Infection Prevention & Control Market Outlook, By Fungal Infections (2017-2027) ($MN)
  • Table 13 Global Infection Prevention & Control Market Outlook, By Viral Infections (2017-2027) ($MN)
  • Table 14 Global Infection Prevention & Control Market Outlook, By Clostridium Difficile Infections (2017-2027) ($MN)
  • Table 15 Global Infection Prevention & Control Market Outlook, By Exserohilum (2017-2027) ($MN)
  • Table 16 Global Infection Prevention & Control Market Outlook, By Bacterial Infections (2017-2027) ($MN)
  • Table 17 Global Infection Prevention & Control Market Outlook, By Products & Services Equipment (2017-2027) ($MN)
  • Table 18 Global Infection Prevention & Control Market Outlook, By Infection Prevention Supplies (2017-2027) ($MN)
  • Table 19 Global Infection Prevention & Control Market Outlook, By Disinfectants (2017-2027) ($MN)
  • Table 20 Global Infection Prevention & Control Market Outlook, By Autoclave (2017-2027) ($MN)
  • Table 21 Global Infection Prevention & Control Market Outlook, By Protective Apparel & Textiles (2017-2027) ($MN)
  • Table 22 Global Infection Prevention & Control Market Outlook, By Safety-Enhanced Medical Devices (2017-2027) ($MN)
  • Table 23 Global Infection Prevention & Control Market Outlook, By Sterilization Supplies (2017-2027) ($MN)
  • Table 24 Global Infection Prevention & Control Market Outlook, By Medical Waste Disposal Supplies (2017-2027) ($MN)
  • Table 25 Global Infection Prevention & Control Market Outlook, By Infection Prevention Equipment (2017-2027) ($MN)
  • Table 26 Global Infection Prevention & Control Market Outlook, By Sterilization Equipment (2017-2027) ($MN)
  • Table 27 Global Infection Prevention & Control Market Outlook, By Washing/Disinfecting Equipment (2017-2027) ($MN)
  • Table 28 Global Infection Prevention & Control Market Outlook, By Endoscope Reprocessors (2017-2027) ($MN)
  • Table 29 Global Infection Prevention & Control Market Outlook, By Other Infection Prevention Equipment (2017-2027) ($MN)
  • Table 30 Global Infection Prevention & Control Market Outlook, By End User (2017-2027) ($MN)
  • Table 31 Global Infection Prevention & Control Market Outlook, By Drug Usage (2017-2027) ($MN)
  • Table 32 Global Infection Prevention & Control Market Outlook, By Individuals & Patients (2017-2027) ($MN)
  • Table 33 Global Infection Prevention & Control Market Outlook, By Nursing & Senior care Centers (2017-2027) ($MN)
  • Table 34 Global Infection Prevention & Control Market Outlook, By Equipment Usage (2017-2027) ($MN)
  • Table 35 Global Infection Prevention & Control Market Outlook, By Medical Laboratories (2017-2027) ($MN)
  • Table 36 Global Infection Prevention & Control Market Outlook, By Manufacturing Units (2017-2027) ($MN)
  • Table 37 Global Infection Prevention & Control Market Outlook, By Hospitals & Clinics (2017-2027) ($MN)
  • Table 38 Global Infection Prevention & Control Market Outlook, By Life Science Industry (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次

According to Stratistics MRC, the Global Infection Prevention & Control Market is accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.

Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.

By products & services equipment, the personal protective equipment segment is anticipated to grow at the significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.

On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.

Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.

Antimicrobial Drugs Covered:

  • Anti-Fungal Drugs
  • Vaccines
  • Anti-Bacterial Drugs
  • Anti-Viral Drugs

Infection Types Covered:

  • Healthcare Associated Infections
  • Microbial infections

Products & Services Equipment Covered:

  • Infection Prevention Supplies
  • Infection Prevention Equipment

End Users Covered:

  • Drug Usage
  • Equipment Usage

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infection Prevention & Control Market, By Antimicrobial Drugs

  • 5.1 Introduction
  • 5.2 Anti-Fungal Drugs
  • 5.3 Vaccines
  • 5.4 Anti-Bacterial Drugs
  • 5.5 Anti-Viral Drugs

6 Global Infection Prevention & Control Market, By Infection Type

  • 6.1 Introduction
  • 6.2 Healthcare Associated Infections
    • 6.2.1 Community Acquired Infection
      • 6.2.1.1 Community Acquired Pneumonia (CAP)
      • 6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection
    • 6.2.2 Hospital Acquired Infection
      • 6.2.2.1 Surgical Site Infection
      • 6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection
      • 6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI)
      • 6.2.2.4 Catheter Associated Urinary Tract Infection
  • 6.3 Microbial infections
    • 6.3.1 Fungal Infections
      • 6.3.1.1 Cryptococcus Gatti
      • 6.3.1.2 Aspergillis
      • 6.3.1.3 Pneumocystis Pneumonia (PCP)
      • 6.3.1.4 Dermatophytes
      • 6.3.1.5 Gungal Keratitis
      • 6.3.1.6 Exserohilum
      • 6.3.1.7 Cladosporium
    • 6.3.2 Viral Infections
      • 6.3.2.1 Herpes Simplex Virus
      • 6.3.2.2 Yellow Fever
      • 6.3.2.3 Dengue Viruses
      • 6.3.2.4 Ebola Virus
      • 6.3.2.5 Junin Virus
      • 6.3.2.6 KFD (Kyasanur Forest Virus)
      • 6.3.2.7 Machupo Virus
      • 6.3.2.8 Human Immunodeficiency Virus (HIV)
    • 6.3.3 Clostridium Difficile Infections
      • 6.3.3.1 Escherichia Coli Infections
      • 6.3.3.2 Helicobacter Pylori
      • 6.3.3.3 Salmonella
    • 6.3.4 Exserohilum
    • 6.3.5 Bacterial Infections
      • 6.3.5.1 Mycobacterium Tuberculosis

7 Global Infection Prevention & Control Market, By Products & Services Equipment

  • 7.1 Introduction
  • 7.2 Infection Prevention Supplies
    • 7.2.1 Disinfectants
      • 7.2.1.1 Surgical Disinfectants
      • 7.2.1.2 Environmental Disinfectants
      • 7.2.1.3 Surface Disinfectants
      • 7.2.1.4 Instrument Disinfectants
      • 7.2.1.5 Skin Disinfectants
      • 7.2.1.6 Hand Sanitizers
      • 7.2.1.7 Disinfectants Wipes
    • 7.2.2 Autoclave
      • 7.2.2.1 Horizontal Autoclave
      • 7.2.2.2 Portable Autoclave
      • 7.2.2.3 Vertical Autoclave
    • 7.2.3 Personal Protective Equipment
      • 7.2.3.1 Medical & Laboratory Gloves
      • 7.2.3.1.1 Examination Gloves
      • 7.2.3.1.2 Surgical Gloves
      • 7.2.3.1.3 Laboratory Gloves
      • 7.2.3.2 Surgical Masks & Respirators
      • 7.2.3.3 Surgical Foot Covers
      • 7.2.3.4 Surgical Drapes
      • 7.2.3.4.1 Nonwoven Drapes
      • 7.2.3.4.2 Plastic Drapes
      • 7.2.3.4.3 Woven Drapes
      • 7.2.3.5 Surgical Gowns
      • 7.2.3.6 Patient Gowns
      • 7.2.3.7 Surgical & Staff Face Masks
      • 7.2.3.8 Other Personal Protective Equipment
      • 7.2.3.8.1 Disposable Staff Apparel
      • 7.2.3.8.2 Disposable Towels & Bedding
    • 7.2.4 Safety-Enhanced Medical Devices
      • 7.2.4.1 Safety-Enhanced Syringes
      • 7.2.4.1.1 Prefillable Syringes
      • 7.2.4.1.2 Safety-Enhanced Clinical Syringes
      • 7.2.4.2 Safety-Enhanced Catheters
      • 7.2.4.2.1 IV Catheters
      • 7.2.4.2.2 Urinary Catheters
      • 7.2.4.3 Safety-Enhanced Blood Collection Tubes
    • 7.2.5 Sterilization Supplies
      • 7.2.5.1 Sterile Containers
      • 7.2.5.2 Sterilization Wrap
      • 7.2.5.3 Sterilization Indicators
    • 7.2.6 Medical Waste Disposal Supplies
      • 7.2.6.1 Medical Waste Disposal Containers
      • 7.2.6.2 Medical Waste Disposal Accessories
  • 7.3 Infection Prevention Equipment
    • 7.3.1 Sterilization Equipment
      • 7.3.1.1 Sterilization Technologies
      • 7.3.1.1.1 Filtration Sterilization
      • 7.3.1.1.2 Radiation Sterilization
      • 7.3.1.1.3 Low Temperature Sterilization
      • 7.3.1.1.3.1 In-House Steam Sterilization
      • 7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization
      • 7.3.1.1.3.3 Gamma and e-Beam Sterilization
      • 7.3.1.1.4 Wet/Stream Sterilization
      • 7.3.1.1.5 Dry Heat Sterilization
      • 7.3.1.1.6 Contract Sterilization Services
    • 7.3.2 Washing/Disinfecting Equipment
    • 7.3.3 Endoscope Reprocessors
    • 7.3.4 Other Infection Prevention Equipment
      • 7.3.4.1 Infectious Waste Receptacles
      • 7.3.4.2 Infectious Waste Processing Units

8 Global Infection Prevention & Control Market, By End User

  • 8.1 Introduction
  • 8.2 Drug Usage
    • 8.2.1 Individuals & Patients
    • 8.2.2 Nursing & Senior care Centers
  • 8.3 Equipment Usage
    • 8.3.1 Medical Laboratories
    • 8.3.2 Manufacturing Units
      • 8.3.2.1 Pharmaceuticals
      • 8.3.2.2 Medical Devices
      • 8.3.2.3 Food & Beverages Industry
    • 8.3.3 Hospitals & Clinics
    • 8.3.4 Life Science Industry

9 Global Infection Prevention & Control Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Danaher Corporation
  • 11.2 Johnson & Johnson
  • 11.3 Becton, Dickinson, and Company
  • 11.4 3M Company
  • 11.5 Baxter International
  • 11.6 Ansell Limited
  • 11.7 Belimed AG
  • 11.8 Aquionics
  • 11.9 Bemis Company Incorporated
  • 11.10 Abbott
  • 11.11 Braun (B.) Melsungen AG
  • 11.12 Cantel Medical Corporation
  • 11.13 Cardinal Health Incorporated
  • 11.14 Covidien
  • 11.15 Henkel
  • 11.16 Simens
  • 11.17 Getinge Group
  • 11.18 Hollister
  • 11.19 Medtronics
  • 11.20 CCP Industries
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.